CAMISASCHI, CHIARA
CAMISASCHI, CHIARA
Universita' degli Studi di MILANO
Reduction of Staphylococcus epidermidis in the mammary tumor microbiota induces antitumor immunity and decreases breast cancer aggressiveness
2023 G. Bernardo, V. Le Noci, E. Ottaviano, L. De Cecco, C. Camisaschi, S. Guglielmetti, M. Di Modica, G. Gargari, F. Bianchi, S. Indino, P. Sartori, E. Borghi, M. Sommariva, E. Tagliabue, T. Triulzi, L. Sfondrini
Y90-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers
2022 L. Rivoltini, S. Bhoori, C. Camisaschi, L. Bergamaschi, L. Lalli, P. Frati, D. Citterio, C. Castelli, V. Mazzaferro
Cyclophosphamide and Vinorelbine Activate Stem-Like CD8+ T Cells and Improve Anti-PD-1 Efficacy in Triple-Negative Breast Cancer
2021 P. Falvo, S. Orecchioni, R. Hillje, A. Raveane, P. Mancuso, C. Camisaschi, L. Luzi, P. Pelicci, F. Bertolini
Efficacy of venetoclax based salvage chemotherapy followed by “Minimal Residual Disease driven”-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia
2020 E. Todisco, F. Gigli, S. Sammassimo, C. Camisaschi, P. Mancuso, C. Ronchini, S. Ramadan, F. Bertolini, R. Pastano, C. Tarella
Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease
2019 F.R. Ponziani, S. Bhoori, C. Castelli, L. Putignani, L. Rivoltini, F. Del Chierico, M. Sanguinetti, D. Morelli, F. Paroni Sterbini, V. Petito, S. Reddel, R. Calvani, C. Camisaschi, A. Picca, A. Tuccitto, A. Gasbarrini, M. Pompili, V. Mazzaferro
pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma
2018 O. Kuchuk, A. Tuccitto, D. Citterio, V. Huber, C. Camisaschi, M. Milione, B. Vergani, A. Villa, M. Alison, S. Carradori, C. Supuran, L. Rivoltini, C. Castelli, V. Mazzaferro
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment
2017 M. Tazzari, V. Indio, B. Vergani, L. De Cecco, F. Rini, T. Negri, C. Camisaschi, M. Fiore, S. Stacchiotti, G.P. Dagrada, P.G. Casali, A. Gronchi, A. Astolfi, M.A. Pantaleo, A. Villa, C. Lombardo, F. Arienti, S. Pilotti, L. Rivoltini, C. Castelli
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30+ T lymphocytes with progression
2014 V. Vallacchi, E. Vergani, C. Camisaschi, P. Deho, A.D. Cabras, M. Sensi, L. De Cecco, N. Bassani, F. Ambrogi, A. Carbone, F. Crippa, B. Vergani, P. Frati, F. Arienti, R. Patuzzo, A. Villa, E. Biganzoli, S. Canevari, M. Santinami, C. Castelli, L. Rivoltini, M. Rodolfo
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class i peptides: Impact on the antigen-specific T cell response
2013 C. Camisaschi, F. P., M. Tazzari, C. C., B. V., L. Pilla, P. R., M. A., C. A., M. M., C.S. V., T. G., S. M., V. B., V. A., E. Berti, U. L., B. P., U. V., P. G., R. L., C. C.
PHENOTYPIC AND FUNCTIONAL MODULATION OF REGULATORY T CELLS IN MELANOMA PATIENTS
2012 C. Camisaschi